Expert Opinion on Pharmacotherapy, Volume 24, Issue 12 (2023)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Pharmacotherapy, Volume 24, Issue 12 (2023)

See all volumes and issues
Vol 25, 2024 Volume 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000
Download citations Download PDFs Download issue

Editorial

Editorial
Is there a pathway for phosphatidylinositol 3-kinase delta inhibitors to be approved therapeutics for B-cell lymphoma therapy
Efrat Luttwak, Mitchell R. Smith & Andrew D. Zelenetz
Pages: 1331-1334
Published online: 12 Jun 2023
First Page PreviewforIs there a pathway for phosphatidylinositol 3-kinase delta inhibitors to be approved therapeutics for B-cell lymphoma therapy | Full Text | References | PDF (656.3 KB) | EPUB
  • 489 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Review

Review Article
New pharmacotherapeutic options for oral anticoagulant treatment in atrial fibrillation patients aged 65 and older: factor XIa inhibitors and beyond
Giovanni Santostasi, Gentian Denas & Vittorio Pengo
Pages: 1335-1347
Published online: 29 May 2023
AbstractforNew pharmacotherapeutic options for oral anticoagulant treatment in atrial fibrillation patients aged 65 and older: factor XIa inhibitors and beyond | Full Text | References | PDF (1.6 MB) | EPUB
  • 184 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Current and emerging pharmacotherapy for the management of hypertrophic cardiomyopathy
Akiva Rosenzveig, Neil Garg, Shiavax J. Rao, Amreen K. Kanwal, Arjun Kanwal, Wilbert S. Aronow & Matthew W. Martinez
Pages: 1349-1360
Published online: 04 Jun 2023
AbstractforCurrent and emerging pharmacotherapy for the management of hypertrophic cardiomyopathy | Full Text | References | PDF (372.6 KB) | EPUB
  • 366 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
An update on Alectinib: a first line treatment for ALK-positive advanced lung cancer
Yourong Zhou, Yiming Yin, Jiangxin Xu, Zhifei Xu, Bo Yang, Qiaojun He, Peihua Luo, Hao Yan & Xiaochun Yang
Pages: 1361-1373
Published online: 13 Jun 2023
AbstractforAn update on Alectinib: a first line treatment for ALK-positive advanced lung cancer | Full Text | References | PDF (395.1 KB) | EPUB
  • 249 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
A review on pharmacological options for the treatment of erectile dysfunction: state of the art and new strategies
Mattia Longoni, Alessandro Bertini, Nicolò Schifano, Emanuele Zaffuto, Paolo Maggio, Rossi Piercarlo, Sara Baldini, Giulio Carcano, Gabriele Antonini, Andrea Salonia, Francesco Montorsi, Federico Dehò & Paolo Capogrosso
Pages: 1375-1386
Published online: 10 Jun 2023
AbstractforA review on pharmacological options for the treatment of erectile dysfunction: state of the art and new strategies | Full Text | References | PDF (416.6 KB) | EPUB
  • 190 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
An update on pharmacotherapy for recurrent depression in 2022
Jean-Baptiste Belge, Amber C.F. Sabbe & Bernard G.C.C. Sabbe
Pages: 1387-1394
Published online: 19 Jun 2023
AbstractforAn update on pharmacotherapy for recurrent depression in 2022 | Full Text | References | PDF (336.9 KB) | EPUB
  • 217 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Pharmacotherapeutic strategies for epithelioid sarcoma: are we any closer to a non-surgical cure?
Magdalena Meissner, Andrea Napolitano, Khin Thway, Paul Huang & Robin L Jones
Pages: 1395-1401
Published online: 20 Jun 2023
AbstractforPharmacotherapeutic strategies for epithelioid sarcoma: are we any closer to a non-surgical cure? | Full Text | References | PDF (336.2 KB) | EPUB
  • 1194 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Meta-Opinion

Indications for mexiletine in the new ESC guidelines and beyond
Mate Vamos, Elod-Janos Zsigmond & Stefan H. Hohnloser
Pages: 1403-1407
Published online: 13 Jun 2023
AbstractforIndications for mexiletine in the new ESC guidelines and beyond | Full Text | References | PDF (1.3 MB) | EPUB
  • 219 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Optimizing drug therapy for older adults: shifting away from problematic polypharmacy
Ruth Daunt et al.
Review Article | Published online: 2 Jul 2024
Open Access
Pharmacotherapeutic options for metabolic dysfunction-associated steatotic liver disease: where are we today?
Tobias Puengel et al.
Review Article | Published online: 2 Jul 2024
Open Access
Fezolinetant: a novel nonhormonal therapy for vasomotor symptoms due to menopause
Megan Z. Roberts et al.
Review Article | Published online: 2 Jul 2024
Recent advances in JAK2 inhibition for the treatment of myelofibrosis
Noa Rippel et al.
Review Article | Published online: 1 Jul 2024
View all latest articles